UnitedHealthcare to End Advance Notification for Most GI Endoscopy Services

Important administrative relief for gastroenterology practices takes effect Oct. 1, 2026.

ASGE welcomes UnitedHealthcare’s (UHC) announcement that it will eliminate its advance notification requirement for gastrointestinal endoscopy services effective Oct. 1, 2026. The change represents meaningful administrative relief for gastroenterologists and their practices and will help reduce barriers that can delay patients’ access to medically necessary care.

In addition to ending the GI endoscopy advance notification program, UHC announced that it will eliminate prior authorization requirements for several high-volume GI procedures, including:

  • 43235 – Esophagogastroduodenoscopy (EGD)
  • 43239 – EGD with biopsy
  • 45378 – Colonoscopy
  • 45380 – Colonoscopy with biopsy
  • 45385 – Colonoscopy with snare removal of lesion

These commonly performed services account for a substantial portion of GI endoscopy volume, making the change particularly significant for GI practices and their patients.

The announcement follows several years of concern within the gastroenterology community regarding UHC’s utilization management requirements for endoscopy. In 2023, UHC initially proposed implementing a prior authorization program for certain GI endoscopy procedures. Following significant concerns raised by the GI community regarding potential delays in care and increased administrative burden, UHC instead implemented an advance notification program.

In summary, effective Oct. 1, 2026, UHC will:

  • End advance notification requirements for GI endoscopy services
  • Reduce prior authorization requirements across its programs, including eliminating requirements for several frequently performed GI procedures

ASGE views these changes as an important step toward reducing unnecessary administrative requirements for gastroenterology practices. The Society will continue to monitor payer utilization management policies and advocate for approaches that support appropriate physician decision-making, reduce administrative burden, and preserve timely access to high-quality GI care.

 Learn more: UnitedHealthcare’s announcement

 

Latest News


About Gastrointestinal Endoscopy
Gastrointestinal endoscopic procedures allow the gastroenterologist to visually inspect the upper gastrointestinal tract (esophagus, stomach and duodenum) and the lower bowel (colon and rectum) through an endoscope, a thin, flexible device with a lighted end and a powerful lens system. Endoscopy has been a major advance in the treatment of gastrointestinal diseases. For example, the use of endoscopes allows the detection of ulcers, cancers, polyps and sites of internal bleeding. Through endoscopy, tissue samples (biopsies) may be obtained, areas of blockage can be opened and active bleeding can be stopped. Polyps in the colon can be removed, which has been shown to prevent colon cancer.

About the American Society for Gastrointestinal Endoscopy
Since its founding in 1941, the American Society for Gastrointestinal Endoscopy (ASGE) has been dedicated to advancing patient care and digestive health by promoting excellence and innovation in gastrointestinal endoscopy. ASGE, with almost 17,000 members worldwide, promotes the highest standards for endoscopic training and practice, fosters endoscopic research, recognizes distinguished contributions to endoscopy, and is the foremost resource for endoscopic education. Visit Asge.org for more information and to find a qualified doctor in your area.

 

American Society for Gastrointestinal Endoscopy
3300 Woodcreek Drive Downers Grove, IL 60515
P (630) 573-0600
F (630) 963-8332

Media Contact

Andrea Lee
Director of Marketing and Communications
630.570.5603
ALee@asge.org